Affymax (AFFY) and Japan's Takeda Pharmaceutical (TKPHF.PK) have voluntarily recalled all lots...

|By:, SA News Editor

Affymax (AFFY) and Japan's Takeda Pharmaceutical (TKPHF.PK) have voluntarily recalled all lots of anemia treatment Omontys in the U.S. following reports of "serious hypersensitivity reactions," including fatalities in "0.02%" of over 25,000 patients after an initial injection. The recall comes after Fresenius said earlier this month that it was halting a pilot program using Omontys. (PR)